Functional neuroimaging techniques including magnetoencephalography (MEG) have demonstrated that the brain is organized into networks displaying correlated activity. Group connectivity differences between healthy controls and participants with major depressive disorder (MDD) can be detected using temporal independent components analysis (ICA) on beta-bandpass filtered Hilbert envelope MEG data. However, the response of these networks to treatment is unknown. Ketamine, an N-methyl-D-aspartate (NMDA) receptor antagonist, exerts rapid antidepressant effects. We obtained MEG recordings before and after open-label infusion of 0.5 mg/kg ketamine in MDD subjects (N¼ 13) and examined networks previously shown to differ between healthy individuals and those with MDD. Connectivity between the amygdala and an insulo-temporal component decreased post-ketamine in MDD subjects towards that observed in control subjects at baseline. Decreased baseline connectivity of the subgenual anterior cingulate cortex (sgACC) with a bilateral precentral network had previously been observed in MDD compared to healthy controls, and the change in connectivity post-ketamine was proportional to the change in sgACC glucose metabolism in a subset (N ¼8) of subjects receiving [11F]FDG-PET imaging. Ketamine appeared to reduce connectivity, regardless of whether connectivity was abnormally high or low compared to controls at baseline. These preliminary findings suggest that sgACC connectivity may be directly related to glutamate levels.
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Introduction
Major depressive disorder (MDD) is a highly prevalent and frequently debilitating disease. Current FDA-approved treatments for MDD are frequently inadequate and require weeks of administration before maximal antidepressant effects appear. In contrast, the N-methyl-D-aspartate (NMDA) antagonist ketamine exerts rapid antidepressant effects that appear within 240 min post-IV infusion, even in treatment-resistant subjects (Zarate et al., 2006) . However, little is known of ketamine's mechanism of action at the molecular level (for a review, see Abdallah et al. (2015) ), and even less is known of ketamine's effects on brain activity in individuals with MDD.
The mechanisms of action of various antidepressant treatments have been studied by investigating their effects on brain connectivity, particularly using resting state functional magnetic resonance imaging (rs-fMRI). Results of these studies do not converge to a common finding (Dichter et al., 2014) . Nevertheless, reports of increased frontal-limbic connectivity following treatment are common (reviewed in Gudayol-Ferre et al. (2015) ); these are hypothesized to represent increased cognitive control over enhanced limbic threat reactivity. In addition, decreased connectivity within the Default Mode Network (DMN)-towards levels seen in healthy controls-has also been reported following treatment with conventional antidepressants (Li et al., 2013; Posner et al., 2013) . Resting state fMRI studies of acute ketamine administration in healthy controls generally report widespread enhanced connectivity (Driesen et al., 2013; Khalili-Mahani et al., 2014) , although both increased and decreased connectivity with sensory/somatosensory networks have been reported (Niesters et al., 2012) . While a substantial literature has investigated the neural correlates of the acute psychotomimetic effects of ketamine administration, relatively few studies have examined brain responses at later time points, such as those associated with antidepressant response after dissociative effects have dissipated. One rs-fMRI study investigated connectivity 24 h post-infusion in healthy control subjects and reported significantly reduced 
